July 17, 2026
Self-issuance, often referred to as direct placement, has become an increasingly strategic capital-raising route for European issuers seeking flexibility, speed, and tighter investor control. In a market shaped by the EU Prospectus Regulation, MiFID II, the Market Abuse Regulation (MAR), and a dense web of national implementing rules, the difference between a compliant direct placement and an accidental public offering can hinge on seemingly minor structural choices.
For finance professionals operating in Europe’s capital markets, understanding what self-issuance (direct placement) under EU securities laws actually means is not just a legal technicality. It is a strategic lever. Whether you are a listed issuer pursuing a targeted institutional placement, a scale-up raising growth capital, or a blockchain-native company structuring tokenized securities, the regulatory architecture determines cost, timing, investor access, and liability exposure.
This guide dissects the concept in depth. We will move beyond surface definitions and into practical mechanics, regulatory triggers, prospectus exemptions, MAR implications, and cross-border distribution pitfalls. The objective is clarity: not theory, but actionable insight anchored in the real EU legal framework.
Self-issuance refers to a transaction structure in which an issuer offers and places its own securities directly with investors, rather than relying on a fully intermediated underwriting or public offering process. In its purest form, the issuer engages investors on its own account and executes subscriptions directly, without a syndicate assuming underwriting risk.
Under EU securities laws, there is no standalone statutory definition of “self-issuance.” Instead, the concept is derived from the absence of an intermediary providing regulated investment services in the placement. The issuer is acting on its own behalf, issuing primary securities directly to selected investors.
Crucially, self-issuance does not mean deregulation. The Prospectus Regulation (Regulation (EU) 2017/1129), MAR (Regulation (EU) 596/2014), and other frameworks apply depending on whether there is an “offer to the public,” an admission to trading, or inside information involved. Self-issuance changes the distribution mechanics—not the regulatory perimeter.
Direct placement typically describes an issuance of securities to a limited group of investors without a public offering and often without underwriting. Unlike an IPO or broadly marketed follow-on, the securities are not offered to the general public across the EU.
In an intermediated distribution, an investment bank or broker may provide underwriting, bookbuilding, or placement services. These services fall squarely within MiFID II regulated activities, triggering authorization, conduct-of-business rules, and product governance requirements. In a self-issued direct placement, the issuer may attempt to avoid engaging a regulated intermediary for distribution.
However, the line can blur. If an issuer uses a placement agent, online platform, or broker-dealer to approach investors, MiFID II authorization requirements likely come into play. Direct placement is not synonymous with regulatory lightness; it is a distribution strategy that must be engineered carefully.
The central actor is the issuer: a company or other legal entity creating new securities. Investors may include qualified investors (as defined in the Prospectus Regulation), professional clients under MiFID II, eligible counterparties, or in some structures, retail investors.
Placement agents or brokers may assist with investor identification and execution. If they perform placement or reception and transmission of orders, they must typically be authorized under MiFID II. Their involvement shifts the regulatory analysis significantly.
Digital platforms introduce additional complexity. Depending on structure, a platform facilitating investment could fall within MiFID II or, in certain cases, the EU Crowdfunding Regulation (Regulation (EU) 2020/1503). The regulatory characterization depends on whether transferable securities are offered and whether investment services are being provided.
A common structure involves the issuer identifying a targeted pool of institutional investors, distributing a confidential information memorandum or investor presentation, and negotiating subscriptions directly. Subscription agreements are executed bilaterally, and securities are issued upon closing.
For listed issuers, accelerated bookbuild-style placements to institutional investors are frequent. Although often supported by banks, some issuers rely on exemptions under the Prospectus Regulation to avoid publishing a full prospectus. The speed advantage can be decisive in volatile markets.
Private companies may conduct growth equity rounds structured as share issuances to selected investors. Even without listing, EU prospectus analysis remains relevant if there is an “offer to the public” in a Member State.
Self-issuance concerns primary issuances—new securities created by the issuer. Secondary sales, by contrast, involve existing shareholders selling securities. While both may involve private placements, the regulatory triggers differ, especially regarding prospectus obligations and disclosure liability.
For listed companies, secondary placements by major shareholders can intersect with MAR obligations and insider dealing concerns. The distinction between issuer-led and shareholder-led transactions matters for disclosure timing and responsibility allocation.
The Prospectus Regulation defines an “offer of securities to the public” broadly as a communication to persons in any form and by any means presenting sufficient information on the offer and the securities to enable an investor to decide to purchase or subscribe. This expansive definition means that even digital communications can qualify.
A private placement aims to rely on exemptions—most commonly the qualified investors exemption or the limited number of offerees exemption. The structure must be engineered so that the transaction does not cross into public offer territory without a compliant prospectus.
Admission of securities to trading on a regulated market independently triggers a prospectus requirement, unless an exemption applies. A purely private issuance with no admission to trading may avoid this trigger, provided no public offer occurs.
Issuers sometimes conduct private placements first and pursue listing later. This sequencing requires careful planning, as subsequent admissions may retroactively affect disclosure analysis and investor expectations.
The Prospectus Regulation (EU) 2017/1129 harmonizes rules across the EU regarding when a prospectus must be published for offers of securities to the public or admissions to trading on regulated markets. It establishes disclosure standards, approval procedures, and passporting mechanisms.
The regulation’s objective is investor protection and market integration. For direct placements, the key question is whether an exemption applies. The analysis is highly fact-specific and sensitive to investor targeting and communication strategy.
MiFID II (Directive 2014/65/EU) and MiFIR govern investment services in the EU. If a third party provides placement, underwriting, reception and transmission of orders, or investment advice, authorization and conduct-of-business rules apply.
Even in a self-issuance context, issuers must consider whether their activities could inadvertently qualify as investment services. While issuers placing their own securities generally benefit from exemptions when acting on their own account, using intermediaries introduces regulatory layering.
MAR applies to financial instruments admitted to trading on regulated markets, MTFs, or OTFs, and to certain instruments whose price depends on them. Direct placements by listed issuers often involve inside information, triggering disclosure, insider list, and market sounding rules.
Fundraising is frequently price-sensitive. The decision to delay disclosure, conduct wall-crossings, or announce accelerated placements must align with MAR’s strict framework. Missteps here are not theoretical risks; enforcement activity across Member States demonstrates regulators’ sensitivity to selective disclosure.
The Transparency Directive (2004/109/EC, as amended) imposes periodic reporting and major shareholding notification obligations on issuers whose securities are admitted to trading on regulated markets. Direct placements that alter ownership structures may trigger threshold notifications.
For issuers listed on regulated markets, significant new issuances can also affect free float, index inclusion, and governance dynamics. The compliance analysis does not end at closing.
The Central Securities Depositories Regulation (CSDR) (Regulation (EU) No 909/2014) governs settlement discipline and CSD operations. If securities are admitted to trading or settled through EU CSDs, issuance mechanics must align with CSDR requirements.
Even private placements may require coordination with a CSD if securities are dematerialized and recorded electronically. Settlement failures can carry financial penalties under CSDR’s discipline regime.
The revised Shareholder Rights Directive (SRD II) strengthens shareholder identification and engagement mechanisms for listed companies. Direct placements that introduce new significant shareholders intersect with these transparency and communication obligations.
Governance structures, especially in negotiated placements, often include board representation or veto rights. These arrangements must be assessed against corporate law and disclosure frameworks.
A prospectus is generally required when securities are offered to the public in a Member State or admitted to trading on a regulated market, unless an exemption applies. The definition of “offer to the public” captures broad marketing communications that enable an investment decision.
Issuers frequently underestimate how easily investor presentations, online postings, or broad email distributions can qualify as public offers. The trigger is substance over form.
Offers addressed solely to qualified investors do not require a prospectus. Qualified investors are defined by reference to MiFID II categories of professional clients and eligible counterparties.
This exemption is the backbone of many institutional private placements. However, the investor base must be strictly controlled and documented.
An offer made to fewer than 150 natural or legal persons per Member State, other than qualified investors, is exempt. This numerical threshold is often used for tightly targeted rounds.
The “per Member State” qualifier is critical. Cross-border communications can inadvertently multiply counts and eliminate reliance on the exemption.
Offers of securities with a minimum denomination of at least EUR 100,000, or addressed to investors who acquire securities for at least EUR 100,000 per investor per offer, benefit from exemptions. These thresholds are common in wholesale debt markets.
Structuring around minimum investment sizes is a practical lever, but it must reflect genuine economic reality, not cosmetic drafting.
Offers where the total consideration in the EU is less than EUR 1 million over 12 months fall outside the Prospectus Regulation entirely. Member States may set higher national thresholds (up to EUR 8 million) for exempt offers subject to local rules.
These small-offer regimes are particularly relevant for early-stage companies but vary across jurisdictions.
Although harmonized, the Prospectus Regulation leaves room for national discretion, particularly regarding small offers. National competent authorities (NCAs) may also differ in supervisory emphasis.
Cross-border direct placements require mapping each targeted jurisdiction’s approach. Assuming uniformity across the EU is a compliance shortcut that can backfire.
If a prospectus is required but not published, the consequences can include administrative fines, civil liability, reputational damage, and potential investor rescission rights under national law. Regulators have demonstrated willingness to enforce disclosure breaches.
The cost of over-compliance is a prospectus. The cost of under-compliance can be strategic paralysis. Sophisticated issuers treat prospectus analysis as a board-level decision.
Issuers placing their own securities generally rely on exemptions from MiFID II authorization when acting on their own account and not providing services to third parties. However, the boundary is not limitless.
If an issuer begins advising investors, transmitting orders, or structuring investments beyond simple issuance, the characterization could shift. Legal analysis must focus on substance.
Engaging a MiFID-authorized firm to place securities introduces full conduct-of-business obligations on that intermediary. Investor categorization, suitability or appropriateness assessments, and product governance rules apply.
While this adds cost, it can also mitigate risk by professionalizing distribution and documentation.
Online platforms facilitating investments in transferable securities may require MiFID II authorization unless they fall under the EU Crowdfunding Regulation. The regulatory perimeter depends on the instrument and structure.
Issuers cannot outsource compliance blindly. Platform selection requires regulatory due diligence.
Investor classification under MiFID II determines the level of protection and disclosure required. Direct placements targeting professional investors reduce regulatory friction but narrow the investor pool.
Allowing retail participation substantially increases disclosure and conduct requirements, often eliminating the practical benefits of private placement exemptions.
Where MiFID firms are involved, product governance obligations require identifying a target market and ensuring distribution aligns with it. High-risk or complex instruments demand particular care.
Direct placement does not mean regulatory invisibility. Distribution architecture must align with investor protection rules.
Mass emails, website postings, social media teasers, or conference presentations can transform a private deal into an offer to the public. The legal test focuses on whether sufficient information is provided to enable an investment decision.
Control of messaging is therefore critical. Confidentiality legends alone do not neutralize broad dissemination.
An offer accessible in multiple Member States can trigger parallel analyses in each jurisdiction. Even digital availability can create cross-border exposure.
Passporting is available only for approved prospectuses. Private placements rely instead on disciplined geographic targeting.
Teasers and term sheets must be carefully drafted to avoid constituting full offer documents. Roadshows involving wall-crossed investors require MAR-compliant procedures for listed issuers.
Every slide deck should be viewed through the lens of regulatory triggers, not just marketing effectiveness.
Maintaining auditable distribution lists and investor qualification evidence is essential. In regulatory investigations, documentation is defense.
Direct placement is disciplined capital formation. Sloppiness in targeting erodes exemption reliance.
For listed issuers, the decision to pursue a capital raise can constitute inside information if it is precise, non-public, and price-sensitive. Timing analysis is nuanced and fact-driven.
Boards must assess at each stage whether MAR disclosure obligations are triggered.
MAR permits delayed disclosure where immediate publication would prejudice legitimate interests, provided confidentiality is maintained. Direct placements often rely on this mechanism during negotiations.
Breakdowns in confidentiality can force premature announcements and disrupt pricing.
Market soundings conducted to gauge investor interest must follow MAR’s procedural safeguards. Insider lists must be maintained meticulously.
Enforcement cases across the EU demonstrate regulators’ attention to insider management failures.
During fundraising, issuers often impose dealing restrictions on insiders. Coordination with closed periods under MAR is necessary.
Trading by insiders during sensitive phases is a litigation magnet.
Listed issuers remain subject to periodic reporting under the Transparency Directive and national rules. Capital raises may alter financial metrics and guidance.
Clear communication post-closing supports market integrity and valuation stability.
Investors crossing thresholds (often 5%, 10%, 15%, etc., depending on Member State implementation) must notify the issuer and regulator. Direct placements frequently trigger such disclosures.
Issuers should coordinate with cornerstone investors to anticipate filings.
New issuances may require updating share registers, articles of association, and shareholder communications. Governance recalibration is often part of negotiated placements.
Ignoring post-deal formalities undermines transactional discipline.
Ordinary shares are common in growth capital rounds. Preferred shares with liquidation preferences and anti-dilution rights appear more frequently in venture-style transactions.
Convertible preferred instruments blend equity upside with downside protection, aligning incentives while managing valuation uncertainty.
Wholesale bonds with EUR 100,000 minimum denominations are standard in institutional markets. Private debt placements often rely on qualified investor exemptions.
Covenant packages and information undertakings substitute for public market transparency.
Convertible bonds allow issuers to reduce coupon costs while offering equity upside. Structuring must consider prospectus triggers and potential dilution disclosure.
Exchangeables referencing third-party shares introduce additional complexity.
Warrants are frequently attached as sweeteners in private placements. Their separate tradability and exercise mechanics must be analyzed under prospectus and MAR frameworks.
Equity-linked instruments demand scenario modeling and disclosure precision.
Term sheets outline economic and governance fundamentals. Precision matters; ambiguity fuels disputes.
Investor presentations must balance marketing clarity with regulatory discipline, particularly regarding forward-looking statements.
Subscription agreements allocate risk and confirm investor status, including representations on qualified investor status where relevant. These representations underpin exemption reliance.
Closing mechanics, conditions precedent, and warranties must align with regulatory analysis.
Negotiated placements often include shareholder agreements granting board seats, veto rights, or information rights. Corporate law and disclosure implications must be assessed.
Governance concessions can be as economically significant as pricing.
Private investors frequently demand enhanced reporting rights. Transfer restrictions preserve exemption reliance and investor composition.
Careful drafting prevents unintended secondary distributions.
Even where no prospectus is required, clear risk disclosure reduces liability exposure. Courts often examine the adequacy of risk communication.
Professional investors expect candor, not marketing gloss.
Targeting qualified or professional investors simplifies compliance. Documentation must substantiate status.
Assumptions without evidence weaken legal defensibility.
Including retail investors may trigger prospectus requirements and full MiFID II conduct standards. The compliance burden increases materially.
Retail participation is possible but rarely compatible with streamlined direct placement objectives.
Anti-money laundering and sanctions screening obligations apply, particularly where financial institutions are involved. Even self-issuers must conduct adequate checks.
AML failures carry criminal as well as regulatory risk.
The General Data Protection Regulation (GDPR) governs personal data processing. Distribution lists and investor records must comply with data minimization and security principles.
Data governance is not peripheral; it is core infrastructure.
Public offerings provide liquidity and broad access but require full prospectus disclosure, regulatory approval, and often underwriting. They are capital-intensive exercises.
Direct placements sacrifice breadth for speed and precision. In volatile markets, that trade-off is often rational.
Rights issues prioritize existing shareholders and often require prospectus-level disclosure. They can be politically attractive but operationally complex.
Direct placements allow selective investor entry, reshaping the cap table strategically.
Crowdfunding under the EU Crowdfunding Regulation targets retail participation under a harmonized regime with caps and platform oversight. It differs structurally from institutional private placements.
Tokenized securities offerings may still qualify as transferable securities under EU law, bringing them within the same prospectus and MiFID perimeter. Technology does not neutralize regulation.
Private equity and venture rounds are forms of direct placement but typically negotiated privately with concentrated investors and detailed governance frameworks.
The regulatory analysis may be lighter where no public offer occurs, but cross-border scaling introduces complexity.
By avoiding full prospectus preparation and regulatory approval, issuers can execute more rapidly. In time-sensitive markets, speed protects valuation.
Professional investor targeting reduces marketing expense and documentation burden.
Selective targeting allows issuers to attract strategic investors aligned with long-term goals. Cap table engineering is strategic finance, not administrative detail.
Direct placements can reset ownership dynamics deliberately.
Terms can be tailored, including pricing, governance, and covenants. This flexibility supports bespoke solutions.
Negotiated flexibility is often the hidden alpha in capital raising.
Misjudging whether an offer is public can invalidate exemption reliance. Broad digital marketing is a common trap.
Precision in communication strategy is non-negotiable.
Improper handling of inside information can result in severe penalties. Fundraising is fertile ground for leaks.
Governance discipline must match ambition.
Multi-jurisdictional offers multiply complexity. National nuances matter.
Centralized oversight with local expertise is best practice.
Privately placed securities may lack liquidity. Investors demand pricing discounts accordingly.
Settlement mechanics must align with CSD infrastructure where relevant.
NCAs across the EU monitor capital markets closely. Enforcement trends demonstrate appetite for sanctioning disclosure and marketing breaches.
Reputation is a capital asset. Regulatory findings erode it quickly.
Map target jurisdictions, investor categories, and listing status. Early legal scoping prevents structural rework.
Analyze whether an offer to the public arises and which exemptions apply. Document reasoning formally.
Implement controlled distribution lists and investor verification processes. Maintain auditable records.
Align term sheets, presentations, and agreements with regulatory analysis. Ensure consistency.
Identify inside information early. Maintain insider lists and control wall-crossings.
Coordinate corporate approvals, issuance mechanics, CSD settlement (if applicable), and required filings. Post-closing discipline preserves transaction integrity.
NCAs vary in supervisory intensity and interpretive guidance. Early informal engagement can clarify expectations in complex cases.
Small-offer thresholds and market norms differ. Local counsel input is indispensable for cross-border deals.
Geoblock marketing materials where appropriate, segment investor outreach by jurisdiction, and harmonize documentation across legal regimes. Cross-border ambition requires operational rigor.
Yes, provided the issuer acts on its own account and does not trigger regulated investment services. However, prospectus and MAR rules may still apply.
When securities are offered to the public or admitted to trading on a regulated market, unless a Prospectus Regulation exemption applies.
They can, but doing so often eliminates reliance on key exemptions and triggers broader regulatory obligations.
It may, depending on the services provided and instrument type. Regulatory due diligence on platforms is essential.
MAR, the Transparency Directive, and ongoing disclosure rules continue to apply, including inside information and major shareholding notifications.
Limit communications to clearly identified exempt investors, avoid broad dissemination, and document exemption reliance meticulously.
The issuance of securities by an issuer directly to investors without full underwriting or broad public distribution.
A targeted offering of securities to selected investors, often relying on prospectus exemptions.
A communication presenting sufficient information on securities and terms to enable an investor to decide to subscribe or purchase.
An investor meeting criteria aligned with MiFID II professional client definitions, eligible for certain prospectus exemptions.
A statutory carve-out under the Prospectus Regulation allowing securities to be offered without publishing an approved prospectus.
Precise, non-public information relating to an issuer or financial instrument that would likely have a significant effect on price if made public.
Book a call with us today and get a free assessment.
